0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Automated Insulin Delivery System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
Published Date: October 2019
|
Report Code: 360I-Auto-3B21
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Automated Insulin Delivery System Market Premium Insight Competitive News Feed Analysis Company Usability Profiles Market Sizing Forecasts to 2025

Global Automated Insulin Delivery System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Code: 360I-Auto-3B21
Report
October 2019
Pages:153
360iResearch
Description
Table of Content
The Global Automated Insulin Delivery System Market is expected to grow from USD 540.45 Millions in 2018 to USD 992.56 Millions by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.07%.

On the basis of Disease Type, the Global Automated Insulin Delivery System Market is studied across Type I Diabetes and Type II Diabetes.

On the basis of Distribution, the Global Automated Insulin Delivery System Market is studied across Diabetes Clinics, Hospital Pharmacies, and Retail Pharmacies.

"Tandem Diabetes Care Inc the potential growing player for the Global Automated Insulin Delivery System Market"

The key players profiled in the Global Automated Insulin Delivery System Market are Tandem Diabetes Care Inc, Eli Lilly and Company, Medtronic plc, Dexcom, Inc., Tidepool, Roche Diabetes Care, Insulet Corporation, Bigfoot Biomedical, Inc., JDRF International, and Tandem Diabetes Care, Inc..

In the report, we have covered two proprietary models, the 360iResearch FPNV Positioning Matrix and 360iResearch Competitive Strategic Window. The 360iResearch FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Automated Insulin Delivery System Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Automated Insulin Delivery System Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Automated Insulin Delivery System Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Automated Insulin Delivery System Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Automated Insulin Delivery System Market

The report answers questions such as:
1. What is the market size of Automated Insulin Delivery System market in the Global?
2. What are the factors that affect the growth in the Global Automated Insulin Delivery System Market over the forecast period?
3. What is the competitive position in the Global Automated Insulin Delivery System Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Automated Insulin Delivery System Market?
5. What are the opportunities in the Global Automated Insulin Delivery System Market?
6. What are the modes of entering the Global Automated Insulin Delivery System Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Automated Insulin Delivery System Market
3.2. Opportunities in the Automated Insulin Delivery System Market
3.3. Geographical Analysis in the Automated Insulin Delivery System Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Rising prevalence of diabetes
4.2.1.2. Increasing awareness campaigns
4.2.2. Restraints
4.2.2.1. Difficulties with the calibration of a glucose sensor, sensor durability, skin-related issues
4.2.3. Opportunities
4.2.3.1. Increasing R&D activities for the production of innovative insulin delivery systems
4.2.3.2. Mild regulatory approval and technical clarity for the use of devices among people
4.2.4. Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Pricing Analysis & Trend
4.4.2. Supply Chain Analysis
5. Global Automated Insulin Delivery System Market, by Disease Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Type I Diabetes
5.4. Type II Diabetes
6. Global Automated Insulin Delivery System Market, by Distribution
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Diabetes Clinics
6.4. Hospital Pharmacies
6.5. Retail Pharmacies
7. Americas Automated Insulin Delivery System Market Estimates & Trend Analysis
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Canada
7.4. Mexico
7.5. United States
8. Asia-Pacific Automated Insulin Delivery System Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. China
8.4. India
8.5. Japan
9. Europe, Middle East & Africa Automated Insulin Delivery System Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. France
9.4. Germany
9.5. United Kingdom
10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix for Global Automated Insulin Delivery System Market
10.2. Market Vendor Ranking Analysis for Global Automated Insulin Delivery System Market
10.3. Competitive News Feed Analysis for Global Automated Insulin Delivery System Market
11. Company Usability Profiles
11.1. Bigfoot Biomedical, Inc.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.1.4. Scorecard
11.2. Eli Lilly and Company
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.2.4. Scorecard
11.3. Insulet Corporation
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.3.4. Scorecard
11.4. Medtronic plc
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.4.4. Scorecard
11.5. Tandem Diabetes Care, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.5.4. Scorecard
11.6. Dexcom, Inc.
11.6.1. Overview
11.6.2. Strategy
11.6.3. SWOT
11.6.4. Scorecard
11.7. JDRF International
11.7.1. Overview
11.7.2. Strategy
11.7.3. SWOT
11.7.4. Scorecard
11.8. Roche Diabetes Care
11.8.1. Overview
11.8.2. Strategy
11.8.3. SWOT
11.8.4. Scorecard
11.9. Tandem Diabetes Care Inc
11.9.1. Overview
11.9.2. Strategy
11.9.3. SWOT
11.9.4. Scorecard
11.10. Tidepool
11.10.1. Overview
11.10.2. Strategy
11.10.3. SWOT
11.10.4. Scorecard
12. Appendix
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Vaccine Contract Manufacturing Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Stem Cells Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Self-Checkout Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global Passenger Security Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4499

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5499

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6499

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart